NRG
39
4
DHI
29
2
AMG
52
3
JNJ
39
4
BMY
33
-2
MKC
53
2
COF
52
5
TRV
42
5
CL
50
3
INTU
57
3
WFC
60
2
PPG
60
3
TJX
54
6
GE
64
4
WMB
62
2
WMT
68
2
PAYX
45
6
PNR
60
3
HST
57
4
CMG
64
3
NRG
39
4
DHI
29
2
AMG
52
3
JNJ
39
4
BMY
33
-2
MKC
53
2
COF
52
5
TRV
42
5
CL
50
3
INTU
57
3
WFC
60
2
PPG
60
3
TJX
54
6
GE
64
4
WMB
62
2
WMT
68
2
PAYX
45
6
PNR
60
3
HST
57
4
CMG
64
3
Financhill
Back

Alkami Technology 10K Form

Buy
60

ALKT
Alkami Technology

Last Price:
$39.95
Seasonality Move:
-11.83%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ALKT News And Ratings

See the #1 stock for the next 7 days that we like better than ALKT

ALKT Financial Statistics

Sales & Book Value

Annual Sales: $264.8M
Cash Flow: $8.7M
Price / Cash Flow: 0
Annual Sales: $3.37
Price / Book: 11.77

Profitability

EPS (TTM): -0.47000
Net Income (TTM): $-45.9M
Gross Margin: $144.1M
Return on Equity: -14.04%
Return on Assets: -10.9%

Alkami Technology Earnings Forecast

Key Alkami Technology Financial Ratios

  • The Gross Profit Margin over the past 5 years for ALKT is 54.42%.
  • The Selling, General & Administrative Expenses for ALKT have been equal to 45.86% of Gross Profit Margin.
  • The Research & Development expenses have been 31.97% of Revenue.
  • The Interest Expense is -11.74% of Operating Income.
  • The Net Earning history of ALKT is -23.76% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 1 years.

Alkami Technology Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Software
Sector: Information Technology
Current Symbol: ALKT
Website: alkami.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.52
Quick Ratio: 2.99

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 77.96

ALKT Technical Analysis vs Fundamental Analysis

Buy
60
Alkami Technology (ALKT) is a Buy

Is Alkami Technology a Buy or a Sell?

  • Alkami Technology stock is rated a Buy
    The current Alkami Technology [ALKT] share price is $39.90. The Score for ALKT is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.